Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Despite annotations declaring readOnly/openWorld/idempotent, the description independently discloses rich behavior: graceful degradation of LEI/FIGI enrichment, explicit `unresolved` identifiers, ambiguous matches returning `figi_candidates`, source-labelled identifiers, and internal cascading through multiple lookup endpoints. No contradiction with annotations exists.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The text is long but organized into a purpose statement, a routing directive, supported types, and behavior/degradation notes. It front-loads the core use and nearly every sentence carries operational value; only the heavy parenthetical asides keep it from being fully as clean as a 5.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the full burden of explaining returns. It does so thoroughly: identifiers returned per type, source labelling, explicit unresolved identifiers, `figi_candidates` on ambiguity, ISIN-to-legal-entity resolution, and graceful degradation when enrichment sources fail. An agent has what it needs to call and interpret the result correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% and both parameters are documented, but the description adds crucial semantic guidance: accepted input forms (ticker, CIK, ISIN, name), the entity-name-only rule with a concrete bond example, and a warning that trailing security-class words match nothing. This prevents a real invocation error the schema alone would not catch.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete natural-language queries and explicitly defines the task: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It names the identifier domains (CIK, ticker, LEI, FIGI, RxCUI) and the two supported types, making it unmistakably distinct from sibling profile or comparison tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The line 'Use FIRST whenever you have a name but need an ID' is an explicit, actionable trigger that tells an agent when to invoke this tool, and the supported-type detail clarifies scope. It does not explicitly name sibling alternatives or state when not to use it, so it falls just short of a perfect routing instruction.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.5/5.0
Disambiguation1/5

Several tools are nearly indistinguishable: ask_pipeworx and ask_pipeworx_beta are explicitly identical in behavior, and ask_pipeworx_grounded overlaps heavily with them. Additionally, entity_profile, compare_entities, deep_research, and validate_claim all cover similar company/factual research territory, creating frequent selection ambiguity.

Naming Consistency2/5

Naming mixes multiple conventions: descriptive lowercase phrases (ai_visibility_check, compare_entities, valid claim) coexist with verb_noun (search_documents, recent_rules) and inconsistent underscores (ask_pipeworx vs ask_pipeworx_grounded, resolve_entity). There is no single recognizable pattern.

Tool Count1/5

The server is named 'Federal Register' but only 3 of 34 tools (search_documents, recent_rules, get_document) relate to that domain. The other 31 tools form a sprawling Pipeworx data and prediction-market suite, making the count extreme and inappropriate for the declared purpose.

Completeness2/5

For the stated Federal Register domain, the surface is minimal: search, recent listing, and single-document retrieval, with no docket browsing, full-text search within documents, or agency-specific navigation. The broader Pipeworx capability set is comprehensive but irrelevant to the server's name, leaving obvious gaps for the actual purpose.